While several chemotherapeutic drugs (inhibitors of Aurora kinase, CHK1, Polo-like kinases (PLKs), survivin, and kinesin-related proteins) induce MC at lower doses, the resulting tetraploid or aneuploid tumor cells are resistant to mitotic abnormalities. Here, BIRC5 is linked to neoplasm.